310 related articles for article (PubMed ID: 18630722)
1. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
[TBL] [Abstract][Full Text] [Related]
2. New therapies aimed at the preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Acta Clin Belg; 2006; 61(5):275-85. PubMed ID: 17240745
[TBL] [Abstract][Full Text] [Related]
3. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
[TBL] [Abstract][Full Text] [Related]
4. [Preventative biology of type 1 diabetes: implications for clinical preventative studies].
Gorus FK; Weets I; Decochez K; van der Auwera BJ
Verh K Acad Geneeskd Belg; 2003; 65(4):203-29; discussion 229-31. PubMed ID: 14534938
[TBL] [Abstract][Full Text] [Related]
5. Cell-based treatments for diabetes.
Jones PM; Courtney ML; Burns CJ; Persaud SJ
Drug Discov Today; 2008 Oct; 13(19-20):888-93. PubMed ID: 18652911
[TBL] [Abstract][Full Text] [Related]
6. Xenotransplantation of purified pre-natal porcine beta cells in mice normalizes diabetes when a short anti-CD4-CD8 antibody treatment is combined with transient insulin injections.
Veld PI; Pavlovic D; Bogdani M; Pipeleers-Marichal M; Pipeleers D
Xenotransplantation; 2006 Sep; 13(5):415-22. PubMed ID: 16925665
[TBL] [Abstract][Full Text] [Related]
7. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
8. Islet neogenesis: a potential therapeutic tool in type 1 diabetes.
Lipsett M; Aikin R; Castellarin M; Hanley S; Jamal AM; Laganiere S; Rosenberg L
Int J Biochem Cell Biol; 2006; 38(4):498-503. PubMed ID: 16216541
[TBL] [Abstract][Full Text] [Related]
9. An update on preventive and regenerative therapies in diabetes mellitus.
Reimann M; Bonifacio E; Solimena M; Schwarz PE; Ludwig B; Hanefeld M; Bornstein SR
Pharmacol Ther; 2009 Mar; 121(3):317-31. PubMed ID: 19168093
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes.
Sanlioglu AD; Griffith TS; Omer A; Dirice E; Sari R; Altunbas HA; Balci MK; Sanlioglu S
J Cell Biochem; 2008 Jun; 104(3):710-20. PubMed ID: 18247339
[TBL] [Abstract][Full Text] [Related]
11. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
Casu A; Trucco M; Pietropaolo M
Pediatr Clin North Am; 2005 Dec; 52(6):1779-804. PubMed ID: 16301093
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
Hu C; Deng S; Wong FS; Wen L
Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell replacement in immunosuppressed recipients: old and new clinical indications.
Bertuzzi F; Ricordi C
Acta Diabetol; 2007 Dec; 44(4):171-6. PubMed ID: 17924054
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
Limbert C; Päth G; Jakob F; Seufert J
Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
16. Restoring a functional beta-cell mass in diabetes.
Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in the treatment of type 1 diabetes mellitus].
Schloot NC; Roden M; Bornstein SR; Brendel MD
Dtsch Med Wochenschr; 2011 Feb; 136(5):172-5. PubMed ID: 21271474
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
[TBL] [Abstract][Full Text] [Related]
19. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
20. [Immunological intervention to preserve beta-cell function in type 1 diabetes].
Schloot NC
Dtsch Med Wochenschr; 2010 May; 135(18):915-21. PubMed ID: 20425677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
